TGF-beta receptor 1 inhibitor (East China Normal University/Texas A&M University)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameTGF-beta receptor 1 inhibitor (East China Normal University/Texas A&M University)
Drug Alias Nametetrahydro beta carboline derivatives (Texas A&M University/East China Normal University)TGFbeta signaling pathway inhibitors (East China Normal University/Texas A&M University)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransforming growth factor beta receptors antagonists
TargetsTransforming growth factor beta receptors
Therapy Area/IndicationsBreast NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesTexas A&M University System
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTexas A&M University SystemEast China Normal University
Active IndicationsN/A
Inactive IndicationsBreast NeoplasmsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A